About
Inflarx N.v. — investor relations, events, news, and company updates on 6ix.
Latest News
May 1 2026
InflaRx to Report First Quarter 2026 Results on May 7, 2026
Apr 9 2026
InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor
Mar 31 2026
InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium
Mar 30 2026
InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting
Mar 19 2026
InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones
Recent Videos

Michelle Medovich from InflaRx on forming new vendor relationships on her own
Mar 31, 2026

InflaRx (IFRX|$54.2M) - 2025 Full Year Earnings Analysis
Mar 20, 2026

IFRX STOCK : RANGE BREAKOUT | INFLARX STOCK
Dec 16, 2025

RANGE BREAKOUT | $IFRX STOCK ANALYSIS | INFLARX STOCK
Nov 14, 2025
Translate